I appreciate your enthusiastic condemnation of the despicable and anti-Semitic Boycott, Divestment, and Sanctions movement.
Bob Menendez
The Public Record
Robert Menendez is a prominent Democratic politician currently serving as a member of the United States Senate, representing New Jersey. He was first elected to the Senate in 2006 and has since been re-elected multiple times. Menendez has played a significant role in various policy areas, including foreign relations, immigration reform, and healthcare. He has served on several Senate committees, including the Senate Foreign Relations Committee, where he has been an advocate for human rights and democracy abroad.
I have been impressed with the French Government's support for democracies in the Eastern Mediterranean like Greece, Cyprus and Israel.
The process of drafting and adopting a new Strategic Concept is critical to the future of NATO.
The President has made it clear that climate considerations shall be an essential element of United States foreign policy and national security.
The United States remains unwavering in its commitment to Israel's security.
I am troubled by Ankara's democratic backsliding and the negative trajectory in terms of freedom of expression, freedom of association, and peaceful assembly in Turkey.
Yes. There is nothing I take more seriously than the health and security of the people who will be working with me.
Before any sort of normalization with Cuba takes place, there must be signs that the Diaz-Canel regime is adhering to long-established benchmarks for democratic governance, respect for human rights, and fundamental freedoms.
Dissuading Egypt from acquiring Su-35 fighter aircraft or any other major new military equipment from Russia is a key priority for the United States.
If confirmed, I will use all tools at my disposal to support independent civil society and democratic actors in Cuba.
If confirmed, I will continue spotlighting Russia's failures to uphold its freely made commitments on human rights, rule of law, and democracy.
Nearly two years into the COVID-19 pandemic access to the COVID-19 vaccine in poor and developing nations remains a challenge.





